A comprehensive view of Oral Medicines / Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Global gummy supplement market anticipated to reach US$48.5B by 2028, growing at a CAGR of 14.5% from 2023-2028; growth driven by appeal of gummies, micronutrient deficiencies worldwide, particularly among children and pregnant women
Published: June 06, 2023 by Globe Newswire
Janssen submits NDA to FDA for approval of single tablet combination therapy of Macitentan and Tadalafil to treat pulmonary arterial hypertension; PAH is a rare blood vessel disorder that constricts small pulmonary arteries, elevates blood pressure
Published: May 30, 2023 by Johnson & Johnson Services Inc.
Janssen and Bristol Myers' Milvexian granted FDA fast track designation for all three indications under evaluation in Phase 3 Librexia program; indications include ischemic stroke, acute coronary syndrome and atrial fibrillation
Published: May 25, 2023 by Johnson & Johnson Services Inc.
Pfizer’s oral Paxlovid nirmatrelvir and ritonavir COVID-19 treatment receives FDA approval for adult patients at high risk of progression to severe COVID-19; about 14,500 cases of COVID-19 were reported each week as of the end of April 2023
Published: May 25, 2023 by Business Wire
Eli Lilly listed a new US clinical trial to study once-daily oral orforglipron LY3502970 in adults with obesity or overweight with weight-related comorbidities
Published: May 25, 2023 by Contify Life Science News

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count